An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis

Romée J.A.L.M. Snijders, Anna E.C. Stoelinga, the Dutch Autoimmune Hepatitis Working Group, Tom J.G. Gevers, Simon Pape, Maaike Biewenga, Maarten E. Tushuizen, Robert C. Verdonk, Hendrik J.M. de Jonge, Jan Maarten Vrolijk, Sjoerd F. Bakker, Thomas Vanwolleghem, Ynto S. de Boer, Martine A.M.C. Baven Pronk, Ulrich Beuers, Adriaan J. van der Meer, Nicole M.F.van Gerven, Marijn G.M. Sijtsma, Brechje C. van Eijck, Manon C. van IJzendoornMargot van Herwaarden, Floris F. van den Brand, Kerem Sebib Korkmaz, Aad P. van den Berg, Maureen M.J. Guichelaar, Amar D. Levens, Bart van Hoek, Joost P.H. Drenth*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

18 Citations (Scopus)
21 Downloads (Pure)

Fingerprint

Dive into the research topics of 'An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science